RISW2025
Back to all people

Ji Lin

Sanofi
1 appearance in the program

Sessions & presentations

PS24: Dose Optimization Statistical and Design Considerations
Presentation: A Seamless Phase II/III Design with Dose Optimization (SDDO) for Oncology Drug Development
Parallel · Thu, Sep 25 , 4:15 PM
CoAuthor
↑